deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT01953744

High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus

Phase 3 Randomized Trial Comparing Fluconazole to Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis Caused by L. Braziliensis and L. Guyanensis

Sponsor: Conselho Nacional de Desenvolvimento Científico e Tecnológico

Conditions Cutaneous Leishmaniasis
Interventions Fluconazole Meglumine Antimoniate
Updated 5 times since 2017 Last updated: Dec 1, 2015 Started: Feb 28, 2014 Primary completion: Apr 30, 2015 Completion: Nov 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Low cure rate in the study (fluconazole) group

Other terminated trials from Conselho Nacional de Desenvolvimento Científico e Tecnológico

See all terminations from Conselho Nacional de Desenvolvimento Científico e Tecnológico

Other Cutaneous Leishmaniasis trials with similar outcome

Browse all Cutaneous Leishmaniasis trials

This PHASE3 trial investigates Cutaneous Leishmaniasis and is currently terminated or withdrawn. Conselho Nacional de Desenvolvimento Científico e Tecnológico leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Federal University of Bahia
  • Hospital Universitário Professor Edgard Santos
Data source: Hospital Universitário Professor Edgard Santos

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations